#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15450	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2164	708.9	0	.	n	.	0	C451T	SNP	451	451	C	700	700	T	867	T,C	439,385	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15450	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2164	708.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1433	1433	C	905	C	850	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15450	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2164	708.9	0	HET	.	.	.	C207T	.	207	207	C	456	456	C	907	C,T	687,161	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27860	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3524	787.2	0	.	n	.	0	T695C	SNP	695	695	T	1021	1021	C	829	C,T	777,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27860	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3524	787.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2297	2297	C	908	C	859	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27860	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3524	787.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2371	2371	A	880	A	845	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27860	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3524	787.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2923	2923	C	827	C	791	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27860	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3524	787.2	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1964	1964	A	896	A,G,T	466,384,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2128	folP	855	855	100.0	folP.l15.c4.ctg.1	1454	145.2	1	SNP	p	R229S	1	.	.	685	687	AGC	973	975	AGC	194;194;194	A;G;C	184;184;184	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5600	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3373	165.4	1	SNP	p	S91F	1	.	.	271	273	TTC	596	598	TTC	178;176;180	T;T,C;C	171;169,1;170	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5600	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3373	165.4	1	SNP	p	D95G	1	.	.	283	285	GGC	608	610	GGC	178;178;177	G;G,A;C	170;168,1;167	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5600	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3373	165.4	1	SNP	p	G95N	0	.	.	283	285	GGC	608	610	GGC	178;178;177	G;G,A;C	170;168,1;167	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1742	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1443	120.3	1	SNP	p	G45D	0	.	.	133	135	GGC	552	554	GGC	224;225;223	G;G;C	207;206;204	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	876	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1096	79.6	0	.	n	.	0	A197.	DEL	197	197	A	571	571	A	194	A	182	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6032	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3063	196.2	1	SNP	p	D86N	0	.	.	256	258	GAC	529	531	GAC	249;252;250	G,T;A;C	231,1;230;236	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6032	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3063	196.2	1	SNP	p	R87W	0	.	.	259	261	CGT	532	534	CGT	251;249;248	C,A;G;T	235,1;231;230	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6032	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3063	196.2	1	SNP	p	R87I	0	.	.	259	261	CGT	532	534	CGT	251;249;248	C,A;G;T	235,1;231;230	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6032	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3063	196.2	1	SNP	p	S87R	1	.	.	259	261	CGT	532	534	CGT	251;249;248	C,A;G;T	235,1;231;230	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6032	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3063	196.2	1	SNP	p	S88P	0	.	.	262	264	TCC	535	537	TCC	247;244;241	T;C;C	227;228;228	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4656	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2497	184.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	234;235;236	G;G;C	215;215;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1246	1248	GCC	227;227;227	G;C;C,A	217;220;218,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1249	1251	ATG	228;228;230	A;T;G	219;221;219	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1261	1263	ACC	224;225;225	A;C;C	210;213;215	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1261	1263	ACC	224;225;225	A;C;C	210;213;215	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1762	1764	ACC	217;216;214	A;C;C,T	192;197;196,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1816	1818	GCG	197;194;193	G;C;G	182;182;179	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1816	1818	GCG	197;194;193	G;C;G	182;182;179	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1939	1941	GGT	161;159;160	G;G;T	149;147;149	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1948	1950	AGC	159;159;159	A;G;C	143;144;144	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4156	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	174.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1966	1968	CCG	128;130;131	C,G;C,G;G	92,7;93,2;96	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6232	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3174	196.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1681	1683	CCG	202;206;206	C;C;G	183;193;187	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2730	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1822	148.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	586	586	C	180	C	169	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3092	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1609	191.0	1	SNP	p	G120K	1	.	.	358	360	AAG	647	649	AAG	268;269;271	A,G;A,G;G,C	254,2;259,2;257,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3092	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1609	191.0	1	SNP	p	A121N	1	.	.	361	363	AAC	650	652	AAC	269;269;270	A;A,G,C;C	258;258,2,1;258	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3092	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1609	191.0	1	SNP	p	N121D	0	.	.	361	363	AAC	650	652	AAC	269;269;270	A;A,G,C;C	258;258,2,1;258	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10760	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4713	227.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1150	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1187	96.5	1	SNP	p	V57M	1	.	.	169	171	ATG	563	565	ATG	216;220;222	A;T;G	207;209;213	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
